Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
Condition: Breast Neoplasms Intervention: Other: ctDNA level during neoadjuant chemotherapy Sponsor: First Affiliated Hospital Xi'an Jiaotong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials